Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience

M. Maas; C. E. M. Hollak; E. M. Akkerman; J. F. M. Aerts

Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience

M. Maas, C. E. M. Hollak, E. M. Akkerman, J. F. M. Aerts

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Abstract

Evaluating bone disease in Gaucher disease is a very important part of monitoring patients on therapy. In the Academic Medical Center (AMC) there is ample experience covering the evaluating of bone marrow involvement. Both state of the art Quantitative Chemical Shift Imaging (QCSI) as well as alternatives have been subject of research protocols. Our experiences are described

Original language	English
Pages (from-to)	318-321
Journal	JBR-BTR
Volume	89
Issue number	6
Publication status	Published - 2006

Cite this

@article{f4c8194d68fb4802a92567a221ea2751,

title = "Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience",

abstract = "Evaluating bone disease in Gaucher disease is a very important part of monitoring patients on therapy. In the Academic Medical Center (AMC) there is ample experience covering the evaluating of bone marrow involvement. Both state of the art Quantitative Chemical Shift Imaging (QCSI) as well as alternatives have been subject of research protocols. Our experiences are described",

author = "M. Maas and Hollak, {C. E. M.} and Akkerman, {E. M.} and Aerts, {J. F. M.}",

year = "2006",

language = "English",

volume = "89",

pages = "318--321",

journal = "JBR-BTR",

issn = "0302-7430",

number = "6",

}

TY - JOUR

T1 - Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience

AU - Maas, M.

AU - Hollak, C. E. M.

AU - Akkerman, E. M.

AU - Aerts, J. F. M.

PY - 2006

Y1 - 2006

N2 - Evaluating bone disease in Gaucher disease is a very important part of monitoring patients on therapy. In the Academic Medical Center (AMC) there is ample experience covering the evaluating of bone marrow involvement. Both state of the art Quantitative Chemical Shift Imaging (QCSI) as well as alternatives have been subject of research protocols. Our experiences are described

AB - Evaluating bone disease in Gaucher disease is a very important part of monitoring patients on therapy. In the Academic Medical Center (AMC) there is ample experience covering the evaluating of bone marrow involvement. Both state of the art Quantitative Chemical Shift Imaging (QCSI) as well as alternatives have been subject of research protocols. Our experiences are described

M3 - Article

C2 - 17274590

SN - 0302-7430

VL - 89

SP - 318

EP - 321

JO - JBR-BTR

JF - JBR-BTR

IS - 6

ER -